|
Sign In to gain access to subscriptions and/or personal tools.
|
Overexpression of Grb2 in Inflammatory Lesions and Preneoplastic Foci and Tumors Induced by N-Nitrosodimethylamine in Helicobacter hepaticus—Infected and -Noninfected A/J Mice
Bhalchandra A. Diwan
Intramural Research Support Program, SAIC Frederick
Gayatri Ramakrishna
Laboratory of Comparative Carcinogenesis, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201
Lucy M. Anderson
Laboratory of Comparative Carcinogenesis, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201
Danica Ramljak
Laboratory of Comparative Carcinogenesis, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201
Growth factors bind to membrane receptor tyrosine kinases, resulting in autophosphorylation and subsequent binding to proteins with SH2 domains, including growth factor receptor-bound protein 2 (Grb2). Grb2 bridges receptors to tyrosine kinase substrates such as SHC and SOS, which in turn facilitate the activation of downstream signaling pathways, including Ras and mitogen-activated protein kinase (MAPK). Overexpression of Grb2 has been demonstrated in several types of neoplasia but has not been investigated in liver tumorigenesis. Here we investigated Grb2 expression in liver lesions in N-nitrosodimethylamine (NDMA)-treated Helicobacter hepaticus-infected and -noninfected A/J mice at 1 year of age. Previously, we reported (6) that infection promotes the development of these NDMA-initiated tumors. In controls, Grb2 immunostaining was absent from normal hepatic tissues, whereas the inflammatory lesions in infected livers were positive for cytoplasmic Grb2 in both hepatocytes and infiltrating leukocytes. All preneoplastic foci (7 of 7), 15 of 27 adenomas, and 3 of 7 carcinomas were positive for Grb2 by immunostaining in both infected and noninfected NDMA-initiated livers. Involvement of Grb2 was confirmed by immunoblotting of similarly infected mice at 9 to 18 months of age, showing a 2.5- to 3.3-fold increase in Grb2 protein in infected livers (p < 0.05 compared with uninfected controls) as well as in preneoplastic foci, adenomas, and carcinomas. These livers also showed a 2.5- to 2.8-fold increase in total Ras protein. The results suggest that upregulation of Grb2 is an early event in liver carcinogenesis, whether caused by the bacterial infection or by NDMA. Concomitant upregulation of Ras p21 would ensure transmission of amplified signal from growth factors via Grb2.
Key Words: Mice Grb2 Helicobacter hepaticus liver tumors hepatitis promotion Ras p21
References
- Burr AW, Toole K., Mathew J., Hines JE, Chapman C., Burt AD ( 1996). Transforming growth factor-expression is altered during experimental hepatocarcinogenesis. J Pathol 179: 276-282.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Canella KA, Diwan BA, Gorelick PA, et al (12 coauthors) (1996). Liver tumorigenesis by Helicobacter hepaticus: Consideration of mechanism. In Vivo 10: 285-292.[Web of Science][Medline]
[Order article via Infotrieve]
- Chardin P., Cussac D., Maignan S., Ducruix A. (1995). The Grb2 adaptor. FEBS Lett 369: 47-51.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Clark GJ, Der CJ ( 1995). Aberrant function of the Ras signal transduction pathway in human breast cancer cell lines. Breast Cancer Res Treat 35: 133-144.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Daly RJ, Binder MD, Sutherland RA (1994). Overexpression of Grb2 gene in human breast cancer cell line. Oncogene 9: 2723-2727.[Web of Science][Medline]
[Order article via Infotrieve]
- Diwan BA, Ward JM, Ramljak D., Anderson LM (1997). Promotion by Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosodimethylamine in male A/JCr mice. Toxicol Pathol 25: 597-605.[Abstract/Free Full Text]
- Egan SE, Giddings BW, Brooks MW, Buday L., Sizeland AM, Weinberg RA (1993). Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363: 4551-4553.
- Fox JG, Li X., Yan R., Cahill RJ, Hurley R., Lewis R., Murphy JC (1996). Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: A model of helicobacter-induced carcinogenesis. Infect Immun 64: 1548-1558.[Abstract]
- Hu Z., Evarts RP, Fujio K., Omori N., Omori M., Marsden ER, Thorgeirsson SS (1996). Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/cmet and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis. Carcinogenesis 17: 931-938.[Abstract/Free Full Text]
- Koch CA, Anderson D., Moran FM, Ellis C., Pawson T. (1991). SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252: 668-674.[Abstract/Free Full Text]
- Lowenstein EJ, Daly RJ, Batzer AG, Li W., Margolis B., Lammers R., Ullrich A., Skolnik EY, Bar-Sagi D., Schlessinger J. (1992). The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70: 431-442.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mochida J., Inoue M., Sakuraji N. (1999). Centrosomal localization of Grb2 and its roles in cell proliferation other than adaptor protein in signal transduction in human lung cancer cells. Proc Am Assoc Cancer Res 40: 372.
- Murakami H., Sanderson ND, Nagy P., Marino PA, Merlino G., Thorgeirsson SS (1993). Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor in hepatic oncogenesis. Cancer Res 53: 1719-1723.[Abstract/Free Full Text]
- Myoken Y., Myoken Y., Okamoto T., Sato JD, Kan M., McKeehan WL, Nakahara M., Takada K. (1996). Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumors. J Pathol 178: 429-436.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ramakrishna G., Anderson LM (1998). Levels and membrane localization of the c-K-ras p21 protein in lungs of mice of different strains and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and Aroclor 1254. Carcinogenesis 19: 463-470.[Abstract/Free Full Text]
- Ramljak D., Jones AB, Diwan BA, Perantoni AO, Hochadel JF, Anderson LM (1998). Epidermal growth factor and transforming growth factor-
-associated overexpression of cyclin D1, Cdk4, and c-Myc during hepatocarcinogenesis in Helicobacter hepaticus-infected A/JCr mice. Cancer Res 58: 3590-3597.[Abstract/Free Full Text] - Romero F., Ramos-Morales F., Dominguez A., Rios RM, Schweighoffer F., Tocque B., Pintor-Toro JA, Fischer S., Tortolero M. (1998). Grb2 and its apoptotic isoform Grb3-3 associate with heterogenous nuclear ribonucleoprotein C, and these interactions are modulated by poly (U) RNA. J Biol Chem 27: 7776-7781.
- Schulte-Herman R., Ohde G., Schuppler J., Timmermann-Trosiener I. ( 1981). Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Res 41: 2556-2563.[Abstract/Free Full Text]
- Suen KL, Bustelo XR, Pawson T., Barbacid M. (1993). Molecular cloning of the mouse Grb2 gene: Differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors. Mol Cell Biol 13: 5500-5512.[Abstract/Free Full Text]
- Tanaka M., Gupta R., Mayer BJ (1995). Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adaptor proteins. Mol Cell Biol 15: 6829-6837.[Abstract]
- Tari AM, Hung M-C., Li K., Lopez-Berestein G. (1999). Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Oncogene 18: 1325-1332.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tari AM, Lopez-Berestein G. (1999). Grb2 protein downregulation leads to MAP kinase inactivation and growth inhibition in A431 squamous carcinoma cells. Proc Am Assoc Cancer Res 40: 372.
- Verbeek BS, Adriaansen SS, Rijksen G., Vroom TM (1996). Grb2 overexpression in nuclei and cytoplasm of human breast cells: A histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J Pathol 183: 195-203.[Web of Science]
- Ward JM, Anver MR, Haines DC, Benveniste RE (1994). Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol 145: 959-968.[Abstract]
- Ward JM, Fox JG, Anver MR, et al (1994). Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with novel Helicobacter species. J Natl Cancer Inst 86: 1222-1227.[Abstract/Free Full Text]
- Woitach JT, Conner EA, Wirth PJ, Thorgeirsson SS (1997). Aberrant expression and regulation of hepatic epidermal growth factor receptor in a c-myc transgenic mouse model. J Cell Biochem 64: 651-660.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 28, No. 4,
548-554 (2000)
DOI: 10.1177/019262330002800407

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Avenaud, B. Le Bail, K. Mayo, A. Marais, R. Fawaz, P. Bioulac-Sage, and F. Megraud
Natural History of Helicobacter hepaticus Infection in Conventional A/J Mice, with Special Reference to Liver Involvement
Infect. Immun.,
June 1, 2003;
71(6):
3667 - 3672.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|